Neurodon Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $25M

  • Investors
  • 4

Neurodon General Information

Description

Developer of a therapeutic strategy designed to change the lives of patients suffering from debilitating diseases. The company's novel strategy focuses on halting the process of endoplasmic reticulum stress, which is a major cause of the disease, providing healthcare professionals with new technology and medicines that can effectively cure Parkinson's, Alzheimer's, and Huntington's disease.

Contact Information

Website
www.neurodon.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9800 Conneticuit Drive
  • Crown Point, IN 46307
  • United States
+1 (219)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 9800 Conneticuit Drive
  • Crown Point, IN 46307
  • United States
+1 (219)

Neurodon Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurodon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC $25M Upcoming Pre-Clinical Trials
9. Grant 29-Oct-2023 Completed Pre-Clinical Trials
8. Grant 23-Oct-2023 Completed Pre-Clinical Trials
7. Grant 12-Jul-2023 Completed Pre-Clinical Trials
6. Grant 03-Jan-2022 Completed Startup
5. Angel (individual) 22-Sep-2020 Completed Pre-Clinical Trials
4. Grant 12-Aug-2020 Completed Pre-Clinical Trials
3. Angel (individual) 17-Oct-2019 Completed Startup
2. Seed Round 04-Jan-2019 Completed Startup
1. Grant 24-Sep-2018 $225K Completed Startup
To view Neurodon’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neurodon Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 28

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Neurodon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220016108-A1 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020
CA-3186668-A1 Quinolines that modulate serca and their use for treating disease Pending 20-Jul-2020
EP-4037685-A4 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020
EP-4037685-A1 Quinolines that modulate serca and their use for treating disease Active 20-Jul-2020
EP-4037685-B1 Quinoline that modulate serca and its use for treating disease Active 20-Jul-2020 A61P35/00
To view Neurodon’s complete patent history, request access »

Neurodon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurodon Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute of Diabetes and Digestive and Kidney Diseases Government
Breakthrough T1D Not-For-Profit Venture Capital Minority
Elevate Ventures Venture Capital Minority
The National Institute on Aging (NIA) Government
To view Neurodon’s complete investors history, request access »

Ready to get started?

Request a free trial

Neurodon FAQs

  • When was Neurodon founded?

    Neurodon was founded in 2012.

  • Where is Neurodon headquartered?

    Neurodon is headquartered in Crown Point, IN.

  • What is the size of Neurodon?

    Neurodon has 2 total employees.

  • What industry is Neurodon in?

    Neurodon’s primary industry is Drug Discovery.

  • Is Neurodon a private or public company?

    Neurodon is a Private company.

  • What is Neurodon’s current revenue?

    The current revenue for Neurodon is .

  • How much funding has Neurodon raised over time?

    Neurodon has raised $1M.

  • Who are Neurodon’s investors?

    National Institute of Diabetes and Digestive and Kidney Diseases, Breakthrough T1D, Elevate Ventures, and The National Institute on Aging (NIA) have invested in Neurodon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »